North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
The North America donor blood component market is projected to grow significantly, reaching an estimated US$ 8,048.4 million by 2031, up from US$ 5,482.7 million in 2024, reflecting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2031. This market encompasses the United States, Canada, and Mexico, with North America expected to capture a substantial share of the global market.
Several factors are driving the growth of the donor blood component market in North America. The increasing prevalence of chronic diseases, particularly cancer, has led to a heightened demand for blood transfusions. The aging population, which is more susceptible to medical conditions and surgeries that require blood products, is also contributing to this demand. Furthermore, advancements in blood component separation and storage technologies have enhanced the efficiency and safety of blood transfusions, encouraging healthcare providers to adopt these innovations.
Government initiatives and awareness campaigns aimed at promoting voluntary blood donation have further bolstered the blood supply. The rise in trauma cases, surgical procedures, and organ transplants has created a consistent need for various blood components. In response to this growing demand, blood banks and organizations have intensified their efforts in donor recruitment and blood collection, facilitating market growth in the region.
Market Segmentation Analysis
The North America donor blood component market is segmented by various criteria:
The future of the North America donor blood component market is being shaped by the rising demand for plasma-derived therapies. Advances in treatments for immune disorders and chronic diseases are increasing the need for plasma products. Growing awareness and technological improvements are driving higher plasma collection and processing rates, which are expected to fuel market growth and innovation in the coming years.
Major players in the industry, such as CSL Behring, are investing in advanced plasmapheresis technologies to enhance collection efficiency and yield. The demand for plasma-derived therapies is driving significant growth and innovation in the donor blood component market, with efforts to improve plasma self-sufficiency and expand donor pools gaining momentum.
Country Insights
The North America donor blood component market is primarily segmented by country into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. According to the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed in the U.S. in 2022, leading to a substantial need for blood transfusions, particularly during chemotherapy treatments. Cancer patients often require blood products daily, as chemotherapy and radiation can lead to severe conditions like thrombocytopenia and neutropenia, necessitating platelet and plasma transfusions.
Organizations such as the American National Red Cross and the Association for the Advancement of Blood & Biotherapies are actively working to meet the growing demand for blood components through intensified donor recruitment and blood collection efforts. The American National Red Cross reports that every two seconds, someone in the U.S. requires blood or platelets for various medical needs, highlighting the critical role of blood donation in healthcare.
Company Profiles
Key players in the North America donor blood component market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
Several factors are driving the growth of the donor blood component market in North America. The increasing prevalence of chronic diseases, particularly cancer, has led to a heightened demand for blood transfusions. The aging population, which is more susceptible to medical conditions and surgeries that require blood products, is also contributing to this demand. Furthermore, advancements in blood component separation and storage technologies have enhanced the efficiency and safety of blood transfusions, encouraging healthcare providers to adopt these innovations.
Government initiatives and awareness campaigns aimed at promoting voluntary blood donation have further bolstered the blood supply. The rise in trauma cases, surgical procedures, and organ transplants has created a consistent need for various blood components. In response to this growing demand, blood banks and organizations have intensified their efforts in donor recruitment and blood collection, facilitating market growth in the region.
Market Segmentation Analysis
The North America donor blood component market is segmented by various criteria:
- By Blood Component: The market is divided into Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others. Red Blood Cells are expected to hold the largest market share in 2024.
- By Blood Component Volume: Similar to the above, Red Blood Cells are anticipated to dominate this segment as well.
- By Indication: The market is categorized into Immunosuppression and Oncology, with Immunosuppression expected to hold the largest share in 2024.
- By Immunosuppression: This segment includes Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others, with HIV or AIDS leading in market share.
- By Oncology: The market is segmented into Hematologic malignancies and Solid Tumor Patients, where Hematologic malignancies are projected to have the largest share.
- By Application: This includes Anemia management, Thrombocytopenia treatment, Coagulopathy correction, Supportive care during chemotherapy, Surgery, and Others, with Anemia management expected to lead.
- By Age Group: The market is divided into Adult and Child, with Adults holding the largest share.
- By End User: This includes Hospitals, Oncology centers, Transplant centers, Ambulatory surgical centers, and Others, with Hospitals expected to dominate.
The future of the North America donor blood component market is being shaped by the rising demand for plasma-derived therapies. Advances in treatments for immune disorders and chronic diseases are increasing the need for plasma products. Growing awareness and technological improvements are driving higher plasma collection and processing rates, which are expected to fuel market growth and innovation in the coming years.
Major players in the industry, such as CSL Behring, are investing in advanced plasmapheresis technologies to enhance collection efficiency and yield. The demand for plasma-derived therapies is driving significant growth and innovation in the donor blood component market, with efforts to improve plasma self-sufficiency and expand donor pools gaining momentum.
Country Insights
The North America donor blood component market is primarily segmented by country into the United States, Canada, and Mexico, with the United States holding the largest market share in 2024. According to the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed in the U.S. in 2022, leading to a substantial need for blood transfusions, particularly during chemotherapy treatments. Cancer patients often require blood products daily, as chemotherapy and radiation can lead to severe conditions like thrombocytopenia and neutropenia, necessitating platelet and plasma transfusions.
Organizations such as the American National Red Cross and the Association for the Advancement of Blood & Biotherapies are actively working to meet the growing demand for blood components through intensified donor recruitment and blood collection efforts. The American National Red Cross reports that every two seconds, someone in the U.S. requires blood or platelets for various medical needs, highlighting the critical role of blood donation in healthcare.
Company Profiles
Key players in the North America donor blood component market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. NORTH AMERICA DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 North America Donor Blood Component Market Forecast and Analysis
7. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. NORTH AMERICA DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 North America
15.1.1 North America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 North America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United States: North America Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 United States: North America Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 United States: North America Donor Blood Component Market Share - by Indication
15.1.2.2.4 United States: North America Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 United States: North America Donor Blood Component Market Share - by Oncology
15.1.2.2.6 United States: North America Donor Blood Component Market Share - by Application
15.1.2.2.7 United States: North America Donor Blood Component Market Share - by Age Group
15.1.2.2.8 United States: North America Donor Blood Component Market Share - by End User
15.2.3.3 Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Canada: North America Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Canada: North America Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Canada: North America Donor Blood Component Market Share - by Indication
15.2.3.3.4 Canada: North America Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Canada: North America Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Canada: North America Donor Blood Component Market Share - by Application
15.2.3.3.7 Canada: North America Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Canada: North America Donor Blood Component Market Share - by End User
15.3.4.4 Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Mexico: North America Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 Mexico: North America Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 Mexico: North America Donor Blood Component Market Share - by Indication
15.3.4.4.4 Mexico: North America Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 Mexico: North America Donor Blood Component Market Share - by Oncology
15.3.4.4.6 Mexico: North America Donor Blood Component Market Share - by Application
15.3.4.4.7 Mexico: North America Donor Blood Component Market Share - by Age Group
15.3.4.4.8 Mexico: North America Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. NORTH AMERICA DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 North America Donor Blood Component Market Forecast and Analysis
7. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. NORTH AMERICA DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. NORTH AMERICA DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 North America
15.1.1 North America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 North America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United States: North America Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 United States: North America Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 United States: North America Donor Blood Component Market Share - by Indication
15.1.2.2.4 United States: North America Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 United States: North America Donor Blood Component Market Share - by Oncology
15.1.2.2.6 United States: North America Donor Blood Component Market Share - by Application
15.1.2.2.7 United States: North America Donor Blood Component Market Share - by Age Group
15.1.2.2.8 United States: North America Donor Blood Component Market Share - by End User
15.2.3.3 Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Canada: North America Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Canada: North America Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Canada: North America Donor Blood Component Market Share - by Indication
15.2.3.3.4 Canada: North America Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Canada: North America Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Canada: North America Donor Blood Component Market Share - by Application
15.2.3.3.7 Canada: North America Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Canada: North America Donor Blood Component Market Share - by End User
15.3.4.4 Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Mexico: North America Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 Mexico: North America Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 Mexico: North America Donor Blood Component Market Share - by Indication
15.3.4.4.4 Mexico: North America Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 Mexico: North America Donor Blood Component Market Share - by Oncology
15.3.4.4.6 Mexico: North America Donor Blood Component Market Share - by Application
15.3.4.4.7 Mexico: North America Donor Blood Component Market Share - by Age Group
15.3.4.4.8 Mexico: North America Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Donor Blood Component Market Segmentation
Table 3. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. North America Donor Blood Component Market Segmentation
Table 3. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. North America Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. North America Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. North America Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. North America Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. North America Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. North America Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. North America Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. North America Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. North America Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. North America Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. North America Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. North America Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. North America Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. North America Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. North America Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. North America Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. United States: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Canada: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Mexico: North America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
